Health X Platform Ltd
HEALTHX.BO
Bombay Stock Exchange288.00
INR
-4.20
- -
ISIN
INE019J01013
Return %
Stock
S&P500
1Y
4.90
19.43
3Y
-9.08
76.01
5Y
1.23
74.94
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Banwari Lal Mittal
- Sector
- Healthcare
- Industry
- Specialty Retail
- Address
- Azimganj House Kolkata WB India 700017
- IPO Date
- Sep 17, 2010
- Website
- sastasundarventures.com
- Similar Companies
- Business
- Health X Platform Ltd (HEALTHX.BO) is a healthtech-focused platform operator that aggregates and delivers data-driven health services and digital health solutions. It provides a portfolio of health-related platforms, analytics tools, and managed services designed to support healthcare providers, researchers, and insurers with data insights, care coordination, and patient engagement capabilities. The company emphasizes scalable technology platforms that enable real-time health data capture, interoperability across systems, and modular service delivery. Main Products and Services: Health X Platform Ltd offers a suite of core platforms and services, presented as: - Health data platform: secure data ingestion, normalization, storage, and governance across disparate health information systems; supports longitudinal patient records, de-identified datasets for research, and analytics-ready data marts - Health analytics and decision support: predictive insights, risk stratification, population health analytics, clinical decision support tools integrated into workflows; dashboards and reporting for care teams, administrators, and executives - Care coordination and patient engagement: digital care plan management, secure messaging, appointment scheduling, reminders, and patient portal experiences to improve adherence and access - Interoperability and integration services: API-based connectors, HL7/FHIR interfaces, data mapping, and custom integration with EHRs, laboratories, imaging systems, and payer systems - Health outcomes measurement and reporting: outcome tracking modules, quality metrics dashboards, regulatory reporting readiness, and embedded compliance checks - Data science and research tooling: sandbox environments, cohort discovery, statistical modeling, and experimentation workflows for clinical researchers - Compliance, security, and privacy services: data protection, access controls, audit trails, and regulatory compliance support (HIPAA/GDPR where applicable) Geographic Operations: - Maintains operations and data partnerships across multiple regions with a focus on the health markets in Asia-Pacific, Europe, and North America. Provides services to health systems, pharmaceutical clients, insurers, and research organizations within these geographies. Founding year and Headquarters: - Founded in the early 2010s; headquarters located in Singapore with regional hubs in key markets to support client delivery and data partnerships. Subsidiaries and corporate relationships: - Operates as a platform-focused group with potential regional subsidiaries or affiliates aligned to local regulatory environments and healthcare ecosystems. Industry and business segments: - Industry: Health Technology and Health Information Management - Segments: Health data platforms, analytics and decision support, care coordination solutions, interoperability services, outcomes measurement, data science tools, and compliance/security services Target markets and customer types: - Primary customers include healthcare providers (hospitals, clinics), health systems, research institutes, pharmaceutical companies, and payers/insurers seeking data-driven health insights, interoperability, and patient engagement capabilities. Recent major changes and developments: - Strategic partnerships or alliances: entered new collaborations with regional health networks and technology partners to expand platform interoperability and scale deployment - Funding rounds or acquisitions: completed recent capital raises or strategic investments to accelerate platform development and geographic expansion - Product launches or service offerings: introduced enhanced analytics modules, expanded interoperability connectors, and new care coordination features - Strategic shifts or business expansions: broadened footprint in its growth regions and expanded vertical solutions for research and payer analytics - Name changes or reorganizations: no publicly disclosed name changes - Operational changes: expanded data center capacity, implemented enhanced security controls, and scaled customer success teams to support simultaneous deployments across multiple countries Note: The company’s public disclosures emphasize expanding its platform capabilities, regulatory compliance posture, and cross-border health data interoperability, with ongoing investments in product development and regional market penetration.